Pharmaniaga Bhd (XKLS:7081) Shares Outstanding (EOP): 1,311 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
45 GF Score
Price RM1.16
GF Value RM0.71
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd Shares Outstanding (EOP)?

Pharmaniaga Bhd XKLS:7081 -0.85% 45 Shares Outstanding (EOP) is 1,311 Mil as of Mar. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.71 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Pharmaniaga Bhd's shares outstanding for the quarter that ended in Mar. 2026 was 1,311 Mil.

Pharmaniaga Bhd's quarterly shares outstanding stayed the same from Dec. 2025 (1,311 Mil) to Mar. 2026 (1,311 Mil).

Pharmaniaga Bhd's annual shares outstanding increased from Dec. 2024 (485 Mil) to Dec. 2025 (1,311 Mil). It means Pharmaniaga Bhd issued new shares from Dec. 2024 to Dec. 2025 .


Pharmaniaga Bhd  (XKLS:7081) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Pharmaniaga Bhd Shares Outstanding (EOP) Related Terms


Pharmaniaga Bhd Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd Shares Outstanding (EOP) Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 440.70 440.78 484.86 484.86 1,311.41

Pharmaniaga Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 484.86 484.86 1,311.41 1,311.41 1,311.41

XKLS:7081 vs MCK, COR, CAH: Shares Outstanding (EOP) Comparison

For the Medical Distribution subindustry, Pharmaniaga Bhd's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd Shares Outstanding (EOP) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Shares Outstanding (EOP) falls into.


XKLS:7081
45GF Score
Pharmaniaga Bhd XKLS:7081
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaniaga Bhd Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1,311 Mil mean?
Pharmaniaga Bhd (XKLS:7081) has a Shares Outstanding (EOP) of 1,311 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's Shares Outstanding (EOP) too high?
Pharmaniaga Bhd's current Shares Outstanding (EOP) is 1,311 Mil. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Shares Outstanding (EOP) compare to MCK and COR?
Pharmaniaga Bhd's Shares Outstanding (EOP) of 1,311 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Distribution company?
A good Shares Outstanding (EOP) depends on the Medical Distribution industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current Shares Outstanding (EOP) is 1,311 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.71, compared to a current price of RM1.16 — trading 63.4% above its estimated fair value. The current Shares Outstanding (EOP) is 1,311 Mil. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Shares Outstanding (EOP) is 1,311 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.16 is trading 63.4% above its estimated GF Value™ of RM0.71. GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.

Key valuation signals for XKLS:7081:

  • Shares Outstanding (EOP): 1,311 Mil
  • GF Value™: RM0.71 vs. price of RM1.16 (63.4% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score

Get the complete analysis for XKLS:7081

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM0.71
GF Value